Index of reports
> Cases with Febrile Neutropenia (63)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Herceptin (Trastuzumab) where reactions include febrile neutropenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 63 Next >>
Possible Herceptin side effects in female
Reported by a physician from France on 2012-08-17
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: date of last dose prior to sae: 01/aug/2012
Indication: Breast Cancer
Start date: 2012-08-01
Docetaxel
Dosage: date of last dose prior to sae : 01/aug/2012
Indication: Breast Cancer
Start date: 2012-08-01
Blinded Pertuzumab
Dosage: date of last dose rpior to sae: 01/aug/2012
Indication: Breast Cancer
Start date: 2012-08-01
Other drugs received by patient: Tramadol HCL; Zofran; Acetaminophen; Fluconazole; Solu-Medrol
Possible Herceptin side effects in female
Reported by a physician from Korea, Republic of on 2012-08-15
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Other drugs received by patient: Palonosetron; Chlorpheniramine Maleate; Ircodon; Loperamide; Levofloxacin; Levofloxacin; Potassium Chloride; Spironolactone; Meropenem; Nystatin; Calcium Gluconate; Alginate Sodium; Mannitol; Metoclopramide; Furosemide; Gynobetadine; Meperidine HCL; Chlorhexidine Gluconate; Megestrol Acetate; Fentanyl; Famotidine; Potassium Dihydrogen Phosphate; Ketorolac; Dexamethasone; Pantoprazole; Albuminar-20; Meropenem; Oxytetracycline HCL; Polymyxin B Sulfate; Norepinephrine; Tetracosactrin; Almagate; Calcium Pantothenate / Cyanocobalamin / Nicotinamide / Pyridoxine Hydrochlor; Aprepitant; Aprepitant; Acetaminophen; Povidone Iodine; Pantoprazole; Pantoprazole; Morphine Sulfate; Metronidazole; Levofloxacin; Esomeprazole; Albuminar-20; Albuminar-20; Calcium Citrate with Vitamin D3; Ambroxol; Ondansetron; Dried Ferrous Sulfate; Dexamethasone; Magnesium Sulfate; Morphine Sulfate; Metoclopramide; Ambroxol; Filgrastim; Nicotinamide / Pyridoxine Hydrochloride / Riboflavin / Thiamine Hydrochlorid; Ircodon; Povidone Iodine; Mupirocin; Metronidazole; Levofloxacin; Ondansetron; Combiflex (Unk Ingredients); Metronidazole; Metronidazole; Potassium Chloride; Furosemide; Morphine HCL; Sodium Bicarbonate
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-08-15
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: permanently discontinued
End date: 2012-05-25
Docetaxel
Dosage: permanently discontinued
End date: 2012-05-25
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-25
Docetaxel
Dosage: permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Carboplatin
Dosage: permanently discontinued
End date: 2012-05-25
Herceptin
Dosage: maintanance dose, temporarily interrupted
End date: 2012-05-04
Carboplatin
Dosage: temporarily discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: loading dose, permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-08-03
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB
Possible Herceptin side effects in female
Reported by a physician from Korea, Republic of on 2012-08-01
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Possible Herceptin side effects in female
Reported by a physician from Korea, Republic of on 2012-07-31
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-19
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Gemcitabine Hydrochloride
Dosage: on days 1 and 8 every 21 days
Indication: Breast Cancer
Herceptin
Dosage: within 2 weeks after curative surgery until 52 weeks of therapy was completed
Paclitaxel
Dosage: over 1 h on days 1 and 8 every 21 days
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1
Indication: Breast Cancer
Herceptin
Dosage: over 30 min weekly
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-07-18
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia
Drug(s) suspected as cause:
Paclitaxel
Indication: Breast Cancer
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Gemcitabine Hydrochloride
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Possible Herceptin side effects in female
Reported by a physician from Korea, Democratic People's Republic of on 2012-07-16
Patient: female, weighing 47.9 kg (105.4 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Herceptin
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Pertuzumab
Dosage: date of last dose prior to sae: 14/jun/2012
Indication: Breast Cancer
Start date: 2012-03-29
Xeloda
Dosage: date of last dose prior to sae: 28/jun/2012
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-03-29
Possible Herceptin side effects in female
Reported by a physician from Spain on 2012-07-12
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Pertuzumab
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Herceptin
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Docetaxel
Dosage: last dose prior to sae:11/jun/2012
Indication: Breast Cancer
Start date: 2012-04-30
Blinded Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Insulin; Bromazepam; Acetaminophen; Venlafaxine; Enalapril Maleate; Omeprazole; Gliclazide; Gemfibrozil; Metformin HCL; Atorvastan
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Spain on 2012-07-02
Patient: female, weighing 61.0 kg (134.2 pounds)
Reactions: Mucosal Inflammation, Diarrhoea, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Pertuzumab
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Blinded Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Herceptin
Dosage: maintanance dose, last dose prior to sae:11/jun/2012
Docetaxel
Dosage: last dose prior to sae:11/jun/2012
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Paracetamol; Omeprazole; Enalapril Maleate; Gemfibrozil; Insulin; Atorvastan; Bromazepam; Metformin HCL; Gliclazide; Loperamide; Venlafaxine
Possible Herceptin side effects in female
Reported by a physician from Belgium on 2012-06-29
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxotere
Dosage: 100mg cyclic
Indication: Breast Cancer
Start date: 2012-06-06
Tyverb
Dosage: 1000mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-06
Herceptin
Dosage: 130mg cyclic
Indication: Breast Cancer
Start date: 2012-06-06
Possible Herceptin side effects in female
Reported by a physician from Belgium on 2012-06-21
Patient: female, weighing 66.0 kg (145.2 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: 1000mg per day
Administration route: Oral
Indication: Breast Cancer
Start date: 2012-06-06
Herceptin
Indication: Breast Cancer
Start date: 2012-06-06
Taxotere
Dosage: 100mg cyclic
Indication: Breast Cancer
Start date: 2012-06-06
Possible Herceptin side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-19
Patient:
Reactions: Thrombosis, Headache, Device Related Infection, Peripheral Sensory Neuropathy, Pericardial Effusion, Malaise, Dyspepsia, Granulocytopenia, Hypoxia, Pneumonitis, Blood Alkaline Phosphatase Increased, Hypotension, Anaemia, Hyperglycaemia, Dehydration, Neutropenia, Pain, Bone Pain, Hypokalaemia, Neutropenic Infection, Postoperative Wound Infection, Fatigue, Chest Pain, Depression, Lethargy, Vomiting, Dyspnoea, Lymphopenia, Alanine Aminotransferase Increased, Muscular Weakness, Febrile Neutropenia, Hypophosphataemia, Syncope, Arthralgia, Diarrhoea, Ejection Fraction Decreased, Hypermagnesaemia, Respiratory Tract Infection, Leukopenia, Infection
Drug(s) suspected as cause:
Vinorelbine Tartrate
Dosage: on day 8 and 15 of the 21 days cycle
Indication: Breast Cancer Metastatic
Herceptin
Docetaxel
Indication: Breast Cancer Metastatic
Herceptin
Indication: Breast Cancer Metastatic
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Spain on 2012-06-15
Patient: female, weighing 69.0 kg (151.8 pounds)
Reactions: Mucosal Inflammation, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: maintanance dose
Blinded Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Blinded Pertuzumab
Dosage: maintanance dose
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-30
Docetaxel
Indication: Breast Cancer
Start date: 2012-04-30
Other drugs received by patient: Insulin; Gemfibrozil; Enalapril Maleate; Atorvastan; Bromazepam; Metformin HCL; Omeprazole; Gliclazide; Acetaminophen; Venlafaxine HCL
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-06-15
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-06-08
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-06-08
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid
Possible Herceptin side effects in female
Reported by a physician from Philippines on 2012-06-07
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-31
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Diarrhoea, Disseminated Intravascular Coagulation, Sepsis, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: loading dose, temporarily interrupted
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Carboplatin
Indication: Breast Cancer
Start date: 2012-04-13
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Zofran; Lovaza; Tylenol; Clindamycin
Possible Herceptin side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-30
Patient:
Reactions: Stomatitis, Alanine Aminotransferase Increased, Febrile Neutropenia, Fatigue, Aspartate Aminotransferase Increased, Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Paclitaxel
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Gemcitabine Hydrochloride
Indication: Breast Cancer
Herceptin
Dosage: over 90 min on day 1, followed by 2 mg/kg over 30 min weekly, for a total of 18 doses
Indication: Breast Cancer
Herceptin
Dosage: after curative surgery until 52 weeks of therapy was completed.
Paclitaxel
Indication: Breast Cancer
Gemcitabine Hydrochloride
Dosage: dosages were modified to one step lower than the previous level after withholding treatment
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Canada on 2012-05-24
Patient: female, weighing 73.1 kg (160.8 pounds)
Reactions: Death, Dehydration, Oedema, Febrile Neutropenia, Staphylococcal Bacteraemia, Asthenia, Epistaxis, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Herceptin
Dosage: loading dose
Start date: 2011-09-16
Docetaxel
Indication: Product Used FOR Unknown Indication
Start date: 2011-07-01
Herceptin
Start date: 2011-10-07
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2008-01-01
Herceptin
Start date: 2012-01-06
Docetaxel
Start date: 2011-09-16
End date: 2012-01-06
Other drugs received by patient: Metformin HCL; Hydromorphone HCL; Synthroid; Prochlorperazine; Zofran; Prevacid; Decadron; Crestor; Domperidone; Lyrica; Diamicron; Nystatin
Possible Herceptin side effects in female
Reported by a physician from Germany on 2012-05-16
Patient: female, weighing 86.0 kg (189.2 pounds)
Reactions: Dyspnoea, Diarrhoea, Sepsis, Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Docetaxel
Dosage: form: vials, dose level: 60 mg/m2, dose reduced.
Indication: Breast Cancer
Herceptin
Dosage: form: vials, dose level: 6 mg/kg,permanently discontinued
Indication: Breast Cancer
Start date: 2010-05-04
End date: 2010-07-22
Carboplatin
Dosage: form: vials, dose level 5 auc, dose reduced.
Indication: Breast Cancer
Carboplatin
Start date: 2010-06-15
End date: 2010-07-22
Docetaxel
Start date: 2010-06-15
End date: 2010-07-22
Other drugs received by patient: Dexamethasone; Cellondan; Metoclopramide; Bisoprolol Fumarate; Loperamide; Emend
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-05-14
Patient: female, weighing 84.0 kg (184.8 pounds)
Reactions: Cardiac Failure, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: reported as adriamycin
Indication: Breast Cancer
Start date: 2011-09-21
End date: 2011-10-14
Paclitaxel
Indication: Breast Cancer
Start date: 2011-11-04
End date: 2012-01-01
Herceptin
Indication: Breast Cancer
Start date: 2011-11-04
End date: 2012-01-01
Cyclophosphamide
Dosage: reported as cytoxan
Indication: Breast Cancer
Start date: 2011-09-21
End date: 2011-10-14
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-05-01
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Diarrhoea, Sepsis, Disseminated Intravascular Coagulation, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Docetaxel
Indication: Breast Cancer
Start date: 2012-04-13
Carboplatin
Indication: Breast Cancer
Start date: 2012-04-13
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
Other drugs received by patient: Lovaza; Clindamycin; Tylenol (Caplet); Zofran
Possible Herceptin side effects in female
Reported by a physician from United States on 2012-04-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Indication: Breast Cancer Metastatic
Start date: 2005-10-21
Ixabepilone
Indication: Breast Cancer Metastatic
Start date: 2005-10-21
Carboplatin
Start date: 2005-10-28
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2005-10-21
Herceptin
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from United States on 2012-04-19
Patient: female, weighing 84.0 kg (184.8 pounds)
Reactions: Cardiac Failure, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
Start date: 2011-11-04
End date: 2012-01-01
Paclitaxel
Indication: Breast Cancer
Start date: 2011-11-04
End date: 2012-01-01
Possible Herceptin side effects in male
Reported by a individual with unspecified qualification from Japan on 2012-04-13
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: White Blood Cell Count Decreased, Stomatitis, Renal Disorder, Pain, Febrile Neutropenia, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia, Constipation, Haemoglobin Decreased, Malaise, Platelet Count Decreased, Hiccups, Neutrophil Count Decreased, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 60mg-120mg
Indication: Gastric Cancer Recurrent
Start date: 2011-04-14
End date: 2011-09-21
Xeloda
Dosage: 2 weeks administration followed by 1 week rest
Administration route: Oral
Start date: 2011-08-03
Xeloda
Dosage: 2 weeks administration followed by 1 week rest
Administration route: Oral
Indication: Gastric Cancer Recurrent
Start date: 2011-04-14
End date: 2011-07-06
Herceptin
Start date: 2011-05-11
End date: 2011-06-22
Herceptin
Start date: 2011-08-03
Herceptin
Indication: Gastric Cancer Recurrent
Start date: 2011-04-14
End date: 2011-04-14
Other drugs received by patient: Loperamide HCL; Emend; Decadron; Granisetron; Allopurinol; Voltaren; Gosha-Jinki-GAN; Emend; Hydrocortisone Sodium Succinate; Emend; Dexamethasone Sodium Phosphate
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-04-10
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Fluconazole; Tinzaparin; Vitamin K TAB; Ciprofloxacin Hydrochloride; Omeprazole; Mucosta
Possible Herceptin side effects in female
Reported by a individual with unspecified qualification from Philippines on 2012-04-05
Patient: female, weighing 52.5 kg (115.5 pounds)
Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Herceptin
Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Docetaxel
Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
Indication: Breast Cancer
Start date: 2010-10-26
End date: 2010-11-16
Other drugs received by patient: Vitamin K TAB; Mucosta; Fluconazole; Tinzaparin; Omeprazole; Ciprofloxacin
Page 1 Next >>
|